UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Evaluation and management of pain in children

Authors
Julie Hauer, MD
Barbara L Jones, PhD, MSW
Section Editor
David G Poplack, MD
Deputy Editor
Carrie Armsby, MD, MPH

INTRODUCTION

Assessment and management of pain are essential components of pediatric care. In children, especially young children, it can be challenging to identify the presence and severity of pain, and then to treat the pain. The use of assessment tools based upon cognitive ability is important to ensure that children of all ages receive adequate pain control.

Assessment of pain and an overview of pain management in children will be reviewed here. Pain management for specific pediatric clinical settings and conditions are discussed separately:

Neonatal pain (see "Assessment of neonatal pain" and "Prevention and treatment of neonatal pain")

Procedural pain management and sedation (see "Procedural sedation in children outside of the operating room" and "Selection of medications for pediatric procedural sedation outside of the operating room", section on 'Sedation for painful procedures' and "Pharmacologic agents for pediatric procedural sedation outside of the operating room", section on 'Analgesic agents')

The use of topical anesthetics in children (see "Topical anesthetics in children")

                               

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Apr 2017. | This topic last updated: May 03, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Hauer JM, Wical BS, Charnas L. Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment. Pediatrics 2007; 119:e519.
  2. Hauer J. Identifying and managing sources of pain and distress in children with neurological impairment. Pediatr Ann 2010; 39:198.
  3. Berde CB, Sethna NF. Analgesics for the treatment of pain in children. N Engl J Med 2002; 347:1094.
  4. Beyer JE, Denyes MJ, Villarruel AM. The creation, validation, and continuing development of the Oucher: a measure of pain intensity in children. J Pediatr Nurs 1992; 7:335.
  5. Wong DL, Hockenberry-Eaton M, Wilson D, et al. Wong's Essentials of Pediatric Nursing, Mosby, St Louis 2001. Vol 6.
  6. Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs 1988; 14:9.
  7. Tomlinson D, von Baeyer CL, Stinson JN, Sung L. A systematic review of faces scales for the self-report of pain intensity in children. Pediatrics 2010; 126:e1168.
  8. Hamill JK, Lyndon M, Liley A, Hill AG. Where it hurts: a systematic review of pain-location tools for children. Pain 2014; 155:851.
  9. Breau LM, Camfield C, McGrath PJ, et al. Measuring pain accurately in children with cognitive impairments: refinement of a caregiver scale. J Pediatr 2001; 138:721.
  10. Breau LM, McGrath PJ, Camfield CS, Finley GA. Psychometric properties of the non-communicating children's pain checklist-revised. Pain 2002; 99:349.
  11. Malviya S, Voepel-Lewis T, Burke C, et al. The revised FLACC observational pain tool: improved reliability and validity for pain assessment in children with cognitive impairment. Paediatr Anaesth 2006; 16:258.
  12. Voepel-Lewis T, Merkel S, Tait AR, et al. The reliability and validity of the Face, Legs, Activity, Cry, Consolability observational tool as a measure of pain in children with cognitive impairment. Anesth Analg 2002; 95:1224.
  13. Hunt AM. A survey of signs, symptoms and symptom control in 30 terminally ill children. Dev Med Child Neurol 1990; 32:341.
  14. Hunt A, Burne R. Medical and nursing problems of children with neurodegenerative disease. Palliat Med 1995; 9:19.
  15. Solodiuk J, Curley MA. Pain assessment in nonverbal children with severe cognitive impairments: the Individualized Numeric Rating Scale (INRS). J Pediatr Nurs 2003; 18:295.
  16. Voepel-Lewis T, Malviya S, Tait AR, et al. A comparison of the clinical utility of pain assessment tools for children with cognitive impairment. Anesth Analg 2008; 106:72.
  17. Beyer JE, McGrath PJ, Berde CB. Discordance between self-report and behavioral pain measures in children aged 3-7 years after surgery. J Pain Symptom Manage 1990; 5:350.
  18. Berde C, Wolfe J. Pain, anxiety, distress, and suffering: interrelated, but not interchangeable. J Pediatr 2003; 142:361.
  19. McGrath PA. Development of the World Health Organization Guidelines on Cancer Pain Relief and Palliative Care in Children. J Pain Symptom Manage 1996; 12:87.
  20. WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. p.37. http://apps.who.int/medicinedocs/documents/s19116en/s19116en.pdf. (Accessed on July 07, 2013).
  21. American Academy of Pediatrics. Committee on Psychosocial Aspects of Child and Family Health, Task Force on Pain in Infants, Children, and Adolescents. The assessment and management of acute pain in infants, children, and adolescents. Pediatrics 2001; 108:793.
  22. Fein JA, Zempsky WT, Cravero JP, et al. Relief of pain and anxiety in pediatric patients in emergency medical systems. Pediatrics 2012; 130:e1391.
  23. Association of Paediatric Anaesthetists of Great Britain and Ireland. Good practice in postoperative and procedural pain management, 2nd edition. Paediatr Anaesth 2012; 22 Suppl 1:1.
  24. Stapelkamp C, Carter B, Gordon J, Watts C. Assessment of acute pain in children: development of evidence-based guidelines. Int J Evid Based Healthc 2011; 9:39.
  25. Taddio A, Appleton M, Bortolussi R, et al. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline. CMAJ 2010; 182:E843.
  26. Guideline statement: management of procedure-related pain in children and adolescents. J Paediatr Child Health 2006; 42 Suppl 1:S1.
  27. Friedrichsdorf SJ, Kang TI. The management of pain in children with life-limiting illnesses. Pediatr Clin North Am 2007; 54:645.
  28. Uman LS, Birnie KA, Noel M, et al. Psychological interventions for needle-related procedural pain and distress in children and adolescents. Cochrane Database Syst Rev 2013; :CD005179.
  29. Dart RC, Rumack BH. Intravenous acetaminophen in the United States: iatrogenic dosing errors. Pediatrics 2012; 129:349.
  30. Greco C, Berde C. Pain management for the hospitalized pediatric patient. Pediatr Clin North Am 2005; 52:995.
  31. Bruera E, Sweeney C. Methadone use in cancer patients with pain: a review. J Palliat Med 2002; 5:127.
  32. Ciszkowski C, Madadi P, Phillips MS, et al. Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med 2009; 361:827.
  33. Kelly LE, Rieder M, van den Anker J, et al. More codeine fatalities after tonsillectomy in North American children. Pediatrics 2012; 129:e1343.
  34. Orliaguet G, Hamza J, Couloigner V, et al. A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol. Pediatrics 2015; 135:e753.
  35. FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. Available at: https://www.fda.gov/downloads/Drugs/DrugSafety/UCM553814.pdf (Accessed on April 24, 2017).
  36. New safety measures for prescription codeine and hydrocodone to further restrict use in children and adolescents. Available at: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/59584a-eng.php?_ga=1.144008432.418636605.1493064052 (Accessed on August 01, 2016).
  37. Codeine not to be used in children below 12 years for cough and cold. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2015/04/WC500186162.pdf (Accessed on April 27, 2015).
  38. Baugh RF, Archer SM, Mitchell RB, et al. Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg 2011; 144:S1.
  39. Voronov P, Przybylo HJ, Jagannathan N. Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer. Paediatr Anaesth 2007; 17:684.
  40. FDA Drug Safety Communication: Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death. http://www.fda.gov/Drugs/DrugSafety/ucm313631.htm (Accessed on February 12, 2013).
  41. Codeine Use in Certain Children After Tonsillectomy and/or Adenoidectomy: Drug Safety Communication - Risk of Rare, But Life-Threatening Adverse Events or Death http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm315627.htm (Accessed on August 15, 2012).
  42. Moryl N, Coyle N, Foley KM. Managing an acute pain crisis in a patient with advanced cancer: "this is as much of a crisis as a code". JAMA 2008; 299:1457.
  43. Murphy EJ. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care 2005; 33:311.
  44. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage 2004; 28:497.
  45. Portenoy RK, Sibirceva U, Smout R, et al. Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symptom Manage 2006; 32:532.
  46. Hauer J. Improving comfort in children with severe neurological impairment. Prog Palliat Care 2012; 20:349.